摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

bzAdΦ(CNEt) | 69434-23-7

中文名称
——
中文别名
——
英文名称
bzAdΦ(CNEt)
英文别名
N-benzoyl-2'-deoxy-3'-adenylic acid, 2-chlorophenyl 2-cyanoethyl ester;3'-Adenylic acid, N-benzoyl-2'-deoxy-, 2-chlorophenyl 2-cyanoethyl ester;[(2R,3S,5R)-5-(6-benzamidopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] (2-chlorophenyl) 2-cyanoethyl phosphate
bzA<sub>d</sub>Φ(CNEt)化学式
CAS
69434-23-7
化学式
C26H24ClN6O7P
mdl
——
分子量
598.939
InChiKey
NWCUSZKCOKMJIF-SDHLMFEHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    41
  • 可旋转键数:
    11
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    171
  • 氢给体数:
    2
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    bzAdΦ(CNEt) 在 mesitylenesulfonyl-3-nitrotriazolide 、 作用下, 以 吡啶 为溶剂, 生成
    参考文献:
    名称:
    Synthesis of a gene coding for human lysozyme.
    摘要:
    一个含有130个氨基酸的人类溶菌酶基因已通过将链长为13-18的化学合成寡脱氧核糖核酸进行连接合成。这个拥有401个碱基对的双链被分为52个片段,这些片段通过包含二核苷酸单元缩合的磷酸三酯固相方法制备而成。在合成过程中获得的副产品已进行了表征。
    DOI:
    10.1248/cpb.34.2202
  • 作为产物:
    描述:
    2-氯苯基二氯膦N-甲基咪唑 三乙胺苯磺酸 作用下, 以 1,4-二氧六环甲醇氯仿 为溶剂, 反应 6.25h, 生成 bzAdΦ(CNEt)
    参考文献:
    名称:
    四个十氧代核糖核苷酸的简化液相制备及其初步光谱表征
    摘要:
    dApTpApTpApTpApTpApT,dApTpApTpCpGpApTpApT和dApApApApApApApApApTpTpTly化学合成了四个自互补的十氧杂核糖核苷酸dApTpApTpApTpApTpApT,dApTpApTpCpGpCpApTpApTply。努力集中于使过程尽可能简单,同时在该过程的每个步骤中获得高纯度的产品。根据以下方案,从3'-末端以3'- O-苯甲酰化的单体开始精加工十聚体:单体+单体二聚体+二聚体四聚体+二聚六聚体+四聚体十聚体。中间体和完全封闭的十聚体的纯度通过色谱法和300MHz 1 HN M R.光谱法进行监测。解封闭的十氧杂核糖核苷酸的特征在于它们的UV,CD和1 HNMR。光谱。
    DOI:
    10.1002/hlca.19820650803
点击查看最新优质反应信息

文献信息

  • Simplified Liquid-Phase Preparation of Four Decadeoxyribonucleotides and their Preliminary Spectroscopic Characterization
    作者:William A. Denny、Werner Leupin、David R. Kearns
    DOI:10.1002/hlca.19820650803
    日期:1982.12.15
    Four self-complementary decadeoxyribonucleotides, dApTpApTpApTpApTpApT, dApTpApTpCpGpApTpApT, dApTpApTpGpCpApTpApT and dApApApApApTpTpTpTpT, were chemically synthesized by the phosphotriester procedure. Efforts were concentrated on keeping the procedure as simple as possible, concomitant with obtaining high-purity products at each step of the process. The decamers were elaborated from the 3'-end, starting
    dApTpApTpApTpApTpApT,dApTpApTpCpGpApTpApT和dApApApApApApApApApTpTpTly化学合成了四个自互补的十氧杂核糖核苷酸dApTpApTpApTpApTpApT,dApTpApTpCpGpCpApTpApTply。努力集中于使过程尽可能简单,同时在该过程的每个步骤中获得高纯度的产品。根据以下方案,从3'-末端以3'- O-苯甲酰化的单体开始精加工十聚体:单体+单体二聚体+二聚体四聚体+二聚六聚体+四聚体十聚体。中间体和完全封闭的十聚体的纯度通过色谱法和300MHz 1 HN M R.光谱法进行监测。解封闭的十氧杂核糖核苷酸的特征在于它们的UV,CD和1 HNMR。光谱。
  • Improved Synthesis of Oligodeoxyribonucleotides by Solid-Phase Phosphotriester Method UtilizingO6-[2-(p-Nitrophenyl)ethyl]-2?-deoxyguanosine Derivatives
    作者:Andr� Chollet、Edgar Ayala、Eric H. Kawashima
    DOI:10.1002/hlca.19840670521
    日期:1984.8.8
    The synthesis of oligodeoxyribonucleotides on a cross-linked polystyrene solid support utilizing stable mono- and dinucleotide phosphotriester building blocks is presented. The use of O6[2-(p-nitrophenyl)ethyl]-2′-deoxyguanosine derivatives yields cleaner DNA fragments by suppressing side reactions. Modifications improving the phosphotriester methodology are presented. The purification methods and
    提出了利用稳定的单核苷酸和二核苷酸磷酸三酯结构单元在交联的聚苯乙烯固体载体上合成寡脱氧核糖核苷酸。使用ö 6 [2-(p通过抑制副反应硝基苯基)乙基] -2'-脱氧鸟苷的产率衍生物吸尘器的DNA片段。提出了改进磷酸三酯方法的修饰。描述了合成寡聚脱氧核糖核苷酸的纯化方法和分析。
  • N,N-bis[2-oxo-3-oxazolidinyl]phosphorodiamidic chloride: a novel coupling reagent in the synthesis of oligodeoxyribonucleotides
    作者:S.B. Katti、K.L. Agarwal
    DOI:10.1016/s0040-4039(00)98833-6
    日期:1985.1
    Use of a novel coupling reagent, N,N-bis[2-oxo-3-oxazolidinyl]phosphorodiamidic chloride (BOPDC) in the synthesis of oligodeoxyribonucleotides is described. This reagent allows the synthesis of phosphotriesters in high yields (70–80%) without detectable side reactions. Synthesis of a hexanucleotide, d(A-A-C-C-C-G) is presented as an example.
    描述了一种新颖的偶联剂,N,N-双[2-氧代-3-恶唑烷二基]磷二酰胺基氯化物(BOPDC)在寡聚脱氧核糖核苷酸的合成中的用途。该试剂可以高产率(70-80%)合成磷酸三酯,而没有可检测到的副反应。以六核苷酸d(AACCCG)的合成为例。
  • Nucleoside und Nucleotide Teil 27 Festphasensynthese eines Tridecanucleosid-dodecaphosphats, das die unnatürliche Base 4-Amino-2(1<i>H</i>)-pyridinon enthält, und eines Octanucleosid-heptaphosphats zur Untersuchung der DNA-Polymerase-Spezifität
    作者:Roland Charczuk、Christoph Tamm
    DOI:10.1002/hlca.19870700321
    日期:1987.5.6
    Nucleosides and Nucleotides. Solid Phase Synthesis of a Tridecanucleoside Dodecaphosphate Containing the Unnatural Base 4-Amino-2(1H)-pyridinone and of a Octanucleoside Heptaphosphate for the Determination of the DNA-Polymerase Specificity
    核苷和核苷酸。固相合成包含非天然碱4-氨基-2(1 H)-吡啶酮的十三碳核苷十二磷酸和八磷酸核苷七磷酸以确定DNA聚合酶的特异性
  • Synthesis of Symmetric Oligo-DNA Dimers and Their Formation of Polymeric Supramolecular Assembly
    作者:Yuichi Ohya、Hiroshi Noro、Mamoru Komatsu、Tatsuro Ouchi
    DOI:10.1246/cl.1996.447
    日期:1996.6
    p-Hydroxybenzene was coupled with tetrathymidine or tetraadenosine through phosphodiester bonds to give symmetric oligo-DNA dimers, (T4)2Bz and (A4)2Bz, as components for a polymeric supramolecular assembly. The equivalent mixture of them formed a high-molecular-weight aggregate in aqueous media via complemental hydrogen bonds.
    对羟基苯通过磷酸二酯键与四胸苷或四腺苷偶联,形成对称的寡聚 DNA 二聚体 (T4)2Bz 和 (A4)2Bz,作为聚合超分子组装的组分。它们的等效混合物通过互补氢键在水性介质中形成高分子量聚集体。
查看更多

同类化合物

腺苷-3’-磷酸 胸苷酰-(3'-5')-胸苷氰基乙基磷酰三酯 胸腺嘧啶脱氧核苷3-单磷酸铵盐水合物 胞啶-3'-单磷酸二钠盐 环(腺苷酰(3'-5')尿苷单磷酸酯) 尿苷酸 尿苷溴乙酰甲醇5'-二磷酸酯 尿苷氯乙酰甲醇5'-二磷酸酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-4-羟基-2-(羟基甲基)四氢呋喃-3-基]苯基磷酸氢酯 N-苯甲酰基-2'-脱氧-3'-胞苷酸2-氯苯基2-氰基乙基酯 8-[(E)-苄亚基氨基]-2'-脱氧腺苷3'-(磷酸二氢酯) 5-甲基-2'-脱氧胞苷-3'-磷酸 3'-(二氢磷酸)鸟嘌呤核苷 3'-(1-丁基磷酰)腺苷 2ˊ-脱氧胞苷-3ˊ-一磷酸 2-脱氧腺苷-3-单磷酸酯*铵 2'-脱氧鸟苷 3'-(磷酸二氢酯) 2'-脱氧腺苷酰-(3'-5')-2'-脱氧腺苷酰-(3'-5)-2'-脱氧腺苷 2'-脱氧-3'-胞苷酸二钠盐 2' -脱氧3' -磷酸游离酸 uridine 3'-(2,2,2-trichloroethyl)phosphate triethylammonium salt 5'-O-pivaloyl-2'-O-(tetrahydropyran-2-yl)uridin-3'-yl 2,2-difluoroethyl isopropyl phosphate 3'-O-(di-tert-butoxyphosphoryl)-6-N-benzoyladenosine 2',5'-di-O-tert-butyldimethylsilyluridine 3'-(2,2,2-trichloroethyl)phosphate α-L-threofuranosyl adenine-3′-monophosphate α-L-threofuranosyl thymine-3′-monophosphate N2-2-nitrobenzen-1-yl-2'-deoxyguanosine-3'-phosphate thymidine 3'-monophosphate 3'-(5'-deoxy-5-fluoro)uridylic acid mono[(2R)-2,3-dihydroxypropyl] ester guanosyl-(3',3')-uridine thymidine 3'-hexadecylphosphate Thymidine 3'-(1,2-dimyristoyl-sn-glycero-3-phosphate) Diethyl 5'-O-(tert-butyldimethylsilyl)-N6,N6-diethyl-2'-deoxyadenosine 3'-phosphate 9-β-D-Arabinofuranosylhypoxanthine-3'-phosphate 3'-Cytidylic acid, N-benzoyl-2'-deoxy-5'-O-(9-phenyl-9H-xanthen-9-yl)-, mono(2-chlorophenyl) ester Niacinamide adenylate 2'-deoxyadenosine-3'-triphosphate dCpdU 1-(O3-phosphono-β-D-arabinofuranosyl)-1H-pyrimidine-2,4-dione 2',5'-Di(tert-butyldimethylsilyl)-3'-(ethyl 4-(hydroxymethyl)phenyl phosphate)uridine 2',5'-Di(tert-butyldimethylsilyl)-3'-(ethyl 4-formylphenyl phosphate)uridine 2',5'-Di(tert-butyldimethylsilyl)-3'-(ethyl vinyl phosphate)uridine 2',5'-Di(tert-butyldimethylsilyl)-3'-(ethyl 4-(fluoromethyl)phenyl phosphate)uridine Phosphoric acid (2R,3R,4R,5R)-4-(tert-butyl-dimethyl-silanyloxy)-2-(tert-butyl-dimethyl-silanyloxymethyl)-5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-tetrahydro-furan-3-yl ester 1,2-dibromo-ethyl ester ethyl ester N(6)-(benzoyl)-2'-O-(tert-butyldimethylsilyl)adenosine 3'-(allyl 2-cyanoethyl phosphate) N6-benzoyl-3'-O-[bis(benzyloxy)phosphoryl]-2'-O-(4-methoxybenzyl)adenosine 2'-deoxyguanosine 3'-monophosphate ammonium salt Phosphoric acid dibenzyl ester (2R,3S,5R)-2-hydroxymethyl-5-(6-methylamino-purin-9-yl)-tetrahydro-furan-3-yl ester N6-methyl-2'-deoxyadenosine-3'-phosphate [(2R,3S,5R)-3-[(2,2-dicyano-3-hydroxypropoxy)-(2-methoxyethoxy)phosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl 2,2-dimethylpropanoate